JPS57149229A - Frozen fibrinogen preparation - Google Patents
Frozen fibrinogen preparationInfo
- Publication number
- JPS57149229A JPS57149229A JP56036826A JP3682681A JPS57149229A JP S57149229 A JPS57149229 A JP S57149229A JP 56036826 A JP56036826 A JP 56036826A JP 3682681 A JP3682681 A JP 3682681A JP S57149229 A JPS57149229 A JP S57149229A
- Authority
- JP
- Japan
- Prior art keywords
- solution
- fibrinogen
- preparation
- frozen
- buffer solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
PURPOSE: To prepare the titled preparation exhibiting strong adhesivity in the local application to the microtissue, and effective for the remedy of wound, by freezing a concentrated solution of fibrinogen obtained by adding a monosaccharide to a buffer solution having low salt concentration, keeping the solution at a specific temperature, and dissolving dried fibrinogen to the solution.
CONSTITUTION: A monosaccharide (e.g. glucose, fructose, mannitol, etc.) is added to a buffer solution having low salt concentration and a pH of 5.5W7 (e.g. 0.01W 0.03M citric acid buffer solution) in an amount of 3W6 (W/V)%, and maintained at 20W30°C. Powder of dried fibrinogen is dissolved in the solution to obtain concentrated solution containing 6W10(W/V)% fibrinogen. The solution is disinfected, filtered, poured into ampules, and frozen to obtain the frozen fibrinogen preparation. The preparation is stored at ≤-22°C, and is locally applied together with thrombin, aprotinin, etc. after melting. Dose: 10W30cc of the frozen preparation containing 9% fibrinogen.
COPYRIGHT: (C)1982,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56036826A JPS57149229A (en) | 1981-03-13 | 1981-03-13 | Frozen fibrinogen preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56036826A JPS57149229A (en) | 1981-03-13 | 1981-03-13 | Frozen fibrinogen preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS57149229A true JPS57149229A (en) | 1982-09-14 |
Family
ID=12480544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56036826A Pending JPS57149229A (en) | 1981-03-13 | 1981-03-13 | Frozen fibrinogen preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57149229A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6185304A (en) * | 1984-10-01 | 1986-04-30 | Green Cross Corp:The | Auxiliary for dental treatment |
JPH0196138A (en) * | 1987-10-06 | 1989-04-14 | Green Cross Corp:The | Remedy for abnormal amniorrhexis |
US5385606A (en) * | 1992-07-06 | 1995-01-31 | Kowanko; Nicholas | Adhesive composition and method |
JP2010063504A (en) * | 2008-09-09 | 2010-03-25 | Chemo Sero Therapeut Res Inst | Carboxylic acid-containing biomedical tissue adhesive and method of preparing the same |
-
1981
- 1981-03-13 JP JP56036826A patent/JPS57149229A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6185304A (en) * | 1984-10-01 | 1986-04-30 | Green Cross Corp:The | Auxiliary for dental treatment |
JPH0553766B2 (en) * | 1984-10-01 | 1993-08-10 | Green Cross Corp | |
JPH0196138A (en) * | 1987-10-06 | 1989-04-14 | Green Cross Corp:The | Remedy for abnormal amniorrhexis |
US5385606A (en) * | 1992-07-06 | 1995-01-31 | Kowanko; Nicholas | Adhesive composition and method |
JP2010063504A (en) * | 2008-09-09 | 2010-03-25 | Chemo Sero Therapeut Res Inst | Carboxylic acid-containing biomedical tissue adhesive and method of preparing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8706446A1 (en) | Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same | |
DE3370930D1 (en) | Protracted-release microbiocidal articles containing microbiocides of relatively low water solubility | |
MY101750A (en) | Improvements in or relating to calcium salts. | |
ATE25807T1 (en) | SALINE COMPOSITION. | |
JPS57149229A (en) | Frozen fibrinogen preparation | |
JPS567716A (en) | Preventive and remedy for cerebral angiospasm | |
SU624563A3 (en) | Method of producing insulin alkaline or ammonium salt | |
MY102212A (en) | Cephalosporin salts and injectable compositions. | |
AR248407A1 (en) | Crystalline beta-lactam hydrate | |
KR840002657A (en) | Process for preparing interferon composition | |
WO1995026963A1 (en) | Stable aqueous folinate solution | |
JPS57188515A (en) | Stabilized aqueous dopamine preparation | |
GB1356873A (en) | Fungicidal compositions and their use | |
JPS5677209A (en) | Iodophor composition | |
JPS6479105A (en) | Powder composition for beauty culture pack of occasion preparation type | |
JPS5495737A (en) | Stabilized composition containing carpronium chloride | |
JPS5762218A (en) | Ophthalmic solution | |
JPS53103416A (en) | Preparation of l-malic acid | |
JPS6440591A (en) | Production of warm and cold-reserving agent | |
JPS56144047A (en) | Loosening agent for frozen fish | |
JPS5665079A (en) | Stabilization of ground | |
JPS5569546A (en) | Neutral l-lysine l-malic acid salt monohydrate crystal and its preparation | |
US3118772A (en) | Artificial sweetening composition | |
JPS6440590A (en) | Instant coolant | |
GB1531276A (en) | Treatment of porous structures |